ENOV vs FRT · rev $1.17B vs rev $1.28B
Enovis Corp (ENOV) versus FRT (FRT) — a side-by-side from cached financials, not a winner call.
Enovis Corp (ENOV) is a medical devices company listed on US.
FRT (FRT) common stock.
Latest reported ENOV revenue for 2026-07-03 was $1.17B. Net income was -$10.0M. Revenue was up 98.9% from 2026-04-03 to 2026-07-03. ENOV currently screens at market cap $1.37B.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
ENOV currently screens at market cap $1.37B. FRT currently screens at market cap $0.
Not investment advice. Open the ENOV and FRT stock pages for the full models.
Not investment advice.